Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective observational study of upadacitinib in ulcerative colitis in China
CTR20250610Phase 4Active
- Sponsor
- AbbVie Inc.
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of upadacitinib in autoimmune colitis, sponsored by AbbVie Inc.. Started Apr 2025; status: active.
02
Drugs
upadacitinib
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on CTR20250610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250610.